Scientific Programme Wednesday, 20 May 2015 Society Symposium

Transcription

10th European Congress on Menopause and Andropause,
20 - 22.05.2105,
Madrid, Spain
Scientific Programme
Wednesday, 20 May 2015
Society Symposia
08:00 - 09:00
Roma
Society Symposium - Latinamerica and women in Middle age
Chairs:
Chair: Juan Matzumura
Characteristics of Climateric Symptomatology in Latinamerican women
08:00 - 08:15
Speaker: Juan Enrique Blümel (Santiago, Chile)
Metabolic Syndrome in Latinamerican women
08:15 - 08:30
Speaker: Sonia Cerdas (Costa Rica)
HRT use en Postmenopausal women in Latinamerica
08:30 - 08:45
Speaker: Zully Benitez (Paraguay)
Osteoporosis in Latinamerica
08:45 - 09:00
Speaker: Miranda Carlos (Peru)
Society Symposia
08:00 - 09:00
Potsdam-Stuttgart
Dutch Menopause Society Symposium - Paradigm shift in menopause care
Chairs:
Chair: Ingrid M Pinas (Netherlands)
Chair: Dorenda KE van Dijken (Netherlands)
Redirecting focus to menopause care and adequate management of
symptoms
08:00 - 08:10
Speaker: Ingrid Pinas (Zwolle, Netherlands)
Androgen levels in women with and without ovarian dysfunction:
associations with cardiometabolic parameters
08:10 - 08:25
Speaker: Nadine Daan (Utrecht, Netherlands)
Endometrial changes as an effect of progesterone receptor modulator
use
08:25 - 08:40
Speaker: Inge de Milliano (Amsterdam, Netherlands)
Gyne/cardiology update in middle-aged women
Speaker: Angela Maas (Nijmegen, Netherlands)
Page 1 / 43
08:40 - 08:55
20 - 22.05.2105,
Madrid, Spain
Society Symposia
08:00 - 09:00
Session Room Milan
International Menopause Society The Impact of exercise on morbidity and mortality
Chairs:
Chair: Rod Baber (Mosman, Australia)
Introductory remarks
08:00 - 08:05
Speaker: Rod Baber (Mosman, Australia)
Exercise and risk reduction for CVD
08:05 - 08:20
Speaker: Mary Ann Lumsden (United Kingdom)
Exercise and risk reduction for osteoporosis IMS Symposium: 20th May
08:20 - 08:35
Speaker: Tobie de Villiers (South Africa)
Educating other practitioners on how to assess menopausal women
08:35 - 08:50
Speaker: Susan Davis (Australia)
Question and answer session
Society Symposia
08:00 - 09:00
08:50 - 09:00
Session Room Venezia
British Menopause Society Management of the menopause - are all hormones
equal?
Body identical hormone therapy
08:00 - 08:15
Speaker: Nick Panay (United Kingdom)
Managing symptoms without estrogen - a practical guide
08:15 - 08:30
Speaker: Edward Morris (United Kingdom)
Complementary therapies - what do our patients think?
08:30 - 08:45
Speaker: Heather Currie (United Kingdom)
Questions and Answers
Plenary Session
09:15 - 10:15
08:45 - 09:00
Roma
Menopause, cognition and dementia
Chairs:
Chair: Margaret Rees (Oxford, United Kingdom)
Chair: Placido Llaneza (Oviedo, Spain)
Neurological consequences of premature ovarian failure
09:15 - 09:35
Speaker: Walter Rocca (Rochester, United States)
Hormone therapy: where are we now?
Speaker: Pauline Maki (United States)
Page 2 / 43
09:35 - 09:55
20 - 22.05.2105,
Madrid, Spain
The critical window hypothesis: implications of cognitive outcomes from
the ELITE clinical trial
09:55 - 10:15
Speaker: Victor Henderson (United States)
Parallel Session
11:00 - 12:15
Roma
Climacteric symptoms: new insights
Chairs:
Chair: Tommaso Simoncini (Italy)
Chair: Joachim Calaf Alsina (Barcelona, Spain)
Hot flushes and cardiovascular disease
11:00 - 11:15
Speaker: Tomi Mikkola (Finland)
Resilience, depressed mood, and menopausal symptoms in
postmenopausal women
11:15 - 11:30
Speaker: Placido Llaneza (Oviedo, Spain)
Nonhormonal strategies for hot flushes
11:30 - 11:45
Speaker: Margaret Rees (Oxford, United Kingdom)
Psychosocial interventions in perimenopausal and postmenopausal
women
11:45 - 12:00
Speaker: Nicolas Mendoza (Granada, Spain)
Parallel Session
11:00 - 12:15
12:00 - 12:15
Potsdam-Stuttgart
Urogenital ageing and sexuality
Chairs:
Chair: Angelica Lindén Hirschberg (Stockholm, Sweden)
Chair: Faustino Perez-Lopez (Zaragoza, Spain)
Vulvovaginal atrophy, women’s and couple’s lives
11:00 - 11:15
Speaker: Rossella Nappi (Pavia, Italy)
Estrogen based treatments for genitourinary syndrome
11:15 - 11:30
Speaker: Goran Samsioe (Lund, Sweden)
Non-estrogen based treatments for vaginal atrophy
11:30 - 11:45
Speaker: James Simon (United States)
Sex after breast and gynecological cancer
11:45 - 12:00
Speaker: Rafael Sánchez-Borrego (Spain)
Page 3 / 43
12:00 - 12:15
20 - 22.05.2105,
Madrid, Spain
Sponsored Symposium
11:00 - 12:15
Session Room Milan
Individualising HRT - Considerations in Prescribing
Chairs:
Chair: Santiago Palacios (Madrid, Spain)
CHD metabolic risk factors & HRT
11:00 - 11:10
Speaker: John Stevenson (London, United Kingdom)
Breast cancer & HRT
11:10 - 11:20
Speaker: Joane Marsden (London, United Kingdom)
Parallel Session
11:00 - 12:15
Premature menopause
Chairs:
Chair: Irene Lambrinoudaki (Athens, Greece)
Chair: Lian Ulrich (Copenhagen O, Denmark)
Genetics of premature ovarian failure
11:00 - 11:15
Speaker: Lubna Pal (United States)
Prophylactic ophorectomy: primum non nocere
11:15 - 11:30
Speaker: Walter Rocca (Rochester, United States)
Assisted reproduction and premature ovarian failure
11:30 - 11:45
Speaker: Pedro Barri (Spain)
AMH to predict age of menopause
11:45 - 12:00
Speaker: Dimitrios Goulis (Thessaloniki, Greece)
Expert practical session
12:30 - 13:30
12:00 - 12:15
Roma
Designing and reporting research
Chairs:
Chair: Nicolas Mendoza (Granada, Spain)
Designing and reporting research: Part 1
12:30 - 13:00
Speaker: Iveta Simera (United Kingdom)
Designing and reporting research: Part 2
Speaker: Greyling Peoples (Netherlands)
Page 4 / 43
13:00 - 13:30
20 - 22.05.2105,
Madrid, Spain
Oral Presentations
12:30 - 13:30
Potsdam-Stuttgart
Late Breaking News Abstracts 1
Chairs:
Chair: Rossella Nappi (Pavia, Italy)
Elderly women have a more difficult early postoperative period after
laparotomy for endometrial cancer
Speaker: Yoav Peled (Tel Aviv, Israel)
Outcome of colpocleisis surgery in women over 80 years old with severe
triple compartment pelvic organ prolapse
Speaker: Yoav Peled (Tel Aviv, Israel)
The impact of mutuation position on the gene and family history on
ovarian cancer risk in BRCA1/2 mutuation carriers
Speaker: Natalia Teixeira (Groningen, Netherlands)
Primary osteoporosis in postmenopausal women
Speaker: Qi Yu (Peking, China)
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to
severe dyspareunia and vaginal dryness, symptoms of vulvovaginal
atrophy.
Speaker: Fernand Labrie (Quebec City, Canada)
Parallel Session
12:30 - 13:30
Session Room Milan
Lifestyle and the menopause
Chairs:
Chair: Fidel Hita Contreras (Spain)
Optimizing lifestyle at the menopause
12:30 - 12:45
Speaker: Irene Lambrinoudaki (Athens, Greece)
Exercise and hot flushes
12:45 - 13:00
Speaker: Margaret Rees (Oxford, United Kingdom)
Sleep disturbances at the menopause
13:00 - 13:15
Speaker: Paivi Polo Kantola (Finland)
12:30 - 13:30
Premature ovarian failure
Chairs:
Chair: Dimitrios Goulis (Thessaloniki, Greece)
Page 5 / 43
13:15 - 13:30
20 - 22.05.2105,
Madrid, Spain
Premature ovarian insuficiency: current point of view
12:30 - 13:00
Speaker: Svetlana Vujovics (Belgrade, Serbia)
Premature ovarian insufficiency: modern management
13:00 - 13:30
Hands-on course
12:30 - 13:30
Session Room Lyon
Hands-on course: Minimally Invasive Procedures for Urinary Incontinence
Chairs:
Instructors
Speaker: Linda Cardozo (London, United Kingdom)
Speaker: Dudley Robinson (United Kingdom)
Sponsored Symposium
14:00 - 15:30
Roma
New horizon in menopause treatment
Chairs:
Introduction: Unmet need in menopausal treatment
14:00 - 14:20
Speaker: Santiago Palacios (Madrid, Spain)
How does the tissue selective estrogen complex (TSEC) work?
14:20 - 14:40
Speaker: Christian Egarter (Austria)
Clinical overview of conjugated estrogens/bazedoxifene (CE/BZA)
14:40 - 15:00
Speaker: Steven R. Goldstein (United States)
Which women with a uterus could benefit from estrogens without the
need for a progestin?
15:00 - 15:20
Speaker: Sven O. Skouby (Denmark)
Panel discussion
Parallel Session
16:00 - 17:30
15:20 - 15:30
Roma
Benign gynecology: Endometriosis and fibroids
Chairs:
Chair: Sean Kehoe (Birmingham, United Kingdom)
Chair: Sven O. Skouby (Denmark)
Medical management of endometriosis
Speaker: Charles Chapron (France)
Page 6 / 43
16:00 - 16:15
20 - 22.05.2105,
Madrid, Spain
Selective progesterone receptor modulators in endometriosis
16:15 - 16:30
Speaker: Ludwig Kiesel (Münster, Germany)
The use of selective progesterone receptor modulators in women with
uterine fibroids
16:30 - 16:45
Speaker: Mary Ann Lumsden (United Kingdom)
Endometriosis: the other agenda
16:45 - 17:00
Speaker: Faustino Perez-Lopez (Zaragoza, Spain)
Parallel Session
16:00 - 17:30
17:00 - 17:30
Potsdam-Stuttgart
Urogynecology and urinary incontinence: drug development and surgery
Chairs:
The ageing pelvic floor
16:00 - 16:15
Speaker: Tommaso Simoncini (Italy)
Drug therapy for overactive bladder
16:15 - 16:30
Speaker: Linda Cardozo (London, United Kingdom)
Estrogens and urinary tract infections
16:30 - 16:45
Speaker: Angelica Lindén Hirschberg (Stockholm, Sweden)
Urogynecology and urinary incontinence: drug development and surgery
16:45 - 17:00
Speaker: Iuliana Ceausu (Bucharest, Romania)
Oral Presentations
16:00 - 17:30
17:00 - 17:30
Session Room Milan
Oral Presentation 1
Chairs:
Chair: Rafael Sánchez-Borrego (Spain)
Chair: Paivi Polo Kantola (Finland)
Results of trans obturator tape procedure in Cerrahpasa Faculty of
Medicine
16:00 - 16:11
Speaker: Cemal Tamer Erel (Istanbul, Turkey)
HRT use and breast cancer incidence in the clinical setting of a
menopause unit
Speaker: Francisco Quereda (Alicante, Spain)
Page 7 / 43
16:11 - 16:22
20 - 22.05.2105,
Madrid, Spain
Relationship between body composition, physical fitness and urinary
incontinence in non-institutionalized postmenopausal women: the elderly
EXERNET multicentre study
16:22 - 16:33
Speaker: Beatriz Moreno-Vecino (Toledo, Spain)
Mortality trends in middle aged and older women in the Netherlands:
beneficial effect of menopausal hormone therapy
16:33 - 16:44
Menopausal hormone therapy, depression, headache, vasomotor
symptoms and absence from work: results from 3 years follow up in a
Dutch gynecology clinic
16:44 - 16:55
A normative model of Inhibin B in young males
16:55 - 17:06
Speaker: Amy Miles (Edinburgh, United Kingdom)
Menopause and hormone replacement therapy are important aetiological
factors in hand osteoarthritis: results from a cross-sectional study in
secondary care
17:06 - 17:18
Speaker: Fiona Watt (Oxford, United Kingdom)
Efficacy and security of denosumab. Results of two years treatment
17:18 - 17:30
Speaker: Rocio Luna Guibourg (Barcelona, Spain)
Oral Presentations
16:00 - 17:30
Oral Presentation 2
Chairs:
Chair: Cemal Tamer Erel (Istanbul, Turkey)
Chair: Herman Depypere (Ghent, Belgium)
Finding new breast cancer bio-markers to improve classification and
therapeutic targets: application in Chilean women
16:00 - 16:11
Speaker: Rodrigo Assar (Santiago, Chile)
Sexual function after fractional microablative CO2 laser in women with
vulvovaginal atrophy
16:11 - 16:22
Speaker: Stefano Salvatore (Milan, Italy)
Sedentary lifestyle in middle-aged women is associated with greater
climacteric symptomatology and more obesity
16:22 - 16:33
Speaker: Juan Enrique Blümel (Santiago, Chile)
Cognitive-behavior therapy for menopausal symptoms (hot flushes and
night sweats): moderators and mediators of treatment effects
16:33 - 16:44
Speaker: Myra Hunter (London, United Kingdom)
Targeted assessment of fracture risk in women at midlife
16:44 - 16:55
Speaker: Susan Davis (Australia)
Weight loss related hypothalamic amenorrhea is not associated with
increased arterial stiffness
Speaker: Adam Czyzyk (Poznan, Poland)
Page 8 / 43
16:55 - 17:06
20 - 22.05.2105,
Madrid, Spain
Effects of estrogen, progesterone and estrogen plus progesterone
administration in central and peripheral Brain-derived neurotrophic
factor in female ovariectomized (ovx) rats
17:06 - 17:18
Speaker: Andrea Giannini (Pisa, Italy)
Robotically assisted laparoscopic repair of anterior vaginal wall and
uterine prolapse by lateral suspension with mesh: our experience
17:18 - 17:30
Speaker: Eleonora Russo (Pisa, Italy)
Plenary Session
18:00 - 19:00
Roma
Stem cells for older women : focus on reproduction
Chairs:
Uterine stem cells
18:00 - 18:30
Oogonial stem cells
18:30 - 19:00
Speaker: Richard Anderson (Edinburgh, United Kingdom)
Opening Ceremony / Closing Ceremony
19:00 - 20:00
Roma
Opening Ceremony
Chairs:
Chair: Martin Birkhäuser (Basel, Switzerland)
Chair: Manuel Neves-e-Castro (Portugal)
Chair: Goran Samsioe (Lund, Sweden)
Menopause and its prediction
Speaker: Bart Fauser (Utrecht, Netherlands)
Poster Session
20:00 - 21:00
Poster Session 1
Perceptions and attitudes toward the menopause among climacteric
aged women from Turkey
Speaker: Gamze Fıskin (Istanbul, Turkey)
Page 9 / 43
Exhibition Area
20 - 22.05.2105,
Madrid, Spain
Predictors of incident hypertension in postmenopausal women: a pilot
study
Speaker: Anastasia Sourreti (Athens, Greece)
Vasomotor symptoms and metabolic syndrome in Korean
Speaker: Hyun Tae Park (Seoul, Korea, Republic of)
The menopause specific quality of life and hormone therapy: Turkish
women perspective
Speaker: Nevin Sahin (Istanbul, Turkey)
Factors influencing treatment decisions among menopausal women in 5
European countries
Speaker: Shelli Graham (Boca Raton, United States)
The association between vasomotor symptoms and metabolic health in
peri- and postmenopausal women: a systematic review
Speaker: Gabriella van Dijk (Rotterdam, Netherlands)
The “MenoGuías” of the AEEM (Spanish Menopause Society)
Prevalence of climacteric symptoms in China comparing peri- and
Speaker: Xiangyan Ruan (Beijing, China)
Treatment of climacteric symptoms in breast cancer patients: a
retrospective study from a medication databan
Speaker: Caroline Antoine (Brussels, Belgium)
The effect of Black cumin on body composition: a double blind
randomized placebo-controlled trial among Iranian postmenopausal
women
Speaker: Saadat Parhizkar (Yasuj, Iran, Islamic Republic of)
The effects of natural supplement containing glucosinolates, β-sitosterol
and citrus flavonoids over body and uterine weight and biochemical
parameters in ovariectomized mice
Speaker: Estefano Malaga Correa (Lima, Peru)
Overtreatment with “bioidentical” hormone replacement therapy – a case
report
Speaker: Ksenija Gersak (Ljubljana, Slovenia)
Using the acupressure bands has antiemetic effect in patients having
cisplatin and gemcitabin
Speaker: Gülşah Tanrıverdi (Adana, Turkey)
An epidemiological study of the relationship between dietary patterns of
TCM and the risk of breast cancer in Hong Kong Chinese women
Speaker: Jianping Chen (Hong Kong, Hong Kong)
Changes in self-reported exercise patterns in menopausal women at lowintermediate risk for cardiovascular disease and relation to body mass
index: a prospective survey study and outcome analysis at 5 years
Speaker: Caroline Ball (Rochester, United States)
Page 10 / 43
20 - 22.05.2105,
Madrid, Spain
Urinary calcium levels in women treated with calcium and vitamin D
supplements
Speaker: Maria Del Carmen Burgos Anguita (Almería, Spain)
Relationship between daily intake of milk and doses of calcium and
vitamin D supplements
Lifestyles of Almeria women between 45 and 65 years old
Health issues for menopausal women: the top 11 conditions have
common solutions
Speaker: Gabriella van Dijk (Rotterdam, Netherlands)
Prevalence of vitamin D deficiency in women of Pusan and Gyeongnam
province in Korea
Speaker: Yong Jin Na (Yangsan-si, Gyeongsangnam-do, Korea, Republic of)
The effect of mobile phone short messages system on healthy food
choices among Iranian postmenopausal women
Speaker: Mahdis Vakili (Ahvaz, Iran, Islamic Republic of)
The role of nutrition in the prevention of menopausal symptoms
Speaker: Mahsa Miryan (Ahvaz, Iran, Islamic Republic of)
Sexual function following menopausal hormone treatment: benefits of
multidisciplinary team counseling
Speaker: Mariette Spigt (Zwolle, Netherlands)
Evaluation of sexuality in a pilot sample of mid-aged women of Paraguay
using the short version of the Female Sexual Function Index (FSFI-6)
Speaker: Peter Chedraui
Sexuality aspects in menopausal women of Catalonia and comparative
with other autonomous communities of Spain
Speaker: Francesc Baró (Barcelona, Spain)
Do gynecologists talk about sexual dysfunction with their patients?
Speaker: Luis Hernandez (Barcelona, Spain)
Sexual disorders in Spanish postmenopausal women attended at
outpatient gynaecology
Prevalence and types of female sexual dysfunction of perimenopausal
women in China assessed by validated scores
Relationship between female sexual dysfunction and metabolic syndrome
Speaker: Hakan Ozturk (Izmir, Turkey)
Relationship between genital atrophy and female sexual dysfunction
Assessment of sexual function in women with genital atrophy
Page 11 / 43
20 - 22.05.2105,
Madrid, Spain
Unlicenced estradiol implants - Does efficacy and safety compare to
previous licenced estradiol implants
Management of peri-menopausal women with history menorrhagia with
use of levonorgestrl intra-uterine system (LNG-IUS) providing
progestrogenic component of HRT along with transdermal oestrogen
Speaker: Shashi Singh (Chatham, United Kingdom)
Immunohistochemical assessment of syntomatic postmenopausal
endometrial polyps in tamoxifen users and no users
Speaker: Rafaela Vanin Pinto Ribeiro (Porto Alegre, Brazil)
Case report: management of a 53 year old postmenopausal women with
an intact uterus who had been given unopposed oestrogen for 12 months
Speaker: Rachel Westwick (Bristol, United Kingdom)
Behaviors/attitudes towards hormone replacement therapy (HRT)
treatment for menopausal women in 5 major European countries
Speaker: Shelli Graham (Boca Raton, United States)
Effects of hormone therapy on lipoprotein in postmenopausal Korean
women by route of estrogen administration: impact of micronized
progesterone
Speaker: Kyoung-Young Seo (Seoul, Korea, Republic of)
Relationship between changes in vulvar/vaginal atrophy and changes in
sexual functioning
Speaker: Lucy Abraham (Tadworth, United Kingdom)
Norethisterone may induce its observed increased breast cancer risk
during hormone therapy via the progesterone receptor membrane
component-1?
The mis(t)ery of bioidentical hormones
Speaker: Bojana Pinter (Ljubljana, Slovenia)
Factors determining the use of hormonal therapy in Spanish
Sex-specific effects of chronic antidepressant treatment in middle-aged
rats: impact of citalopram on cognition and depressive-like behaviors
Speaker: Ryoko Hiroi (Tempe, United States)
Abstract withdrawn by the author
Fractional CO2 laser treatment for atrophic vaginitis in breast cancer
patients using aromatase inhibitors
Speaker: Aurelie Joris (Brussels, Belgium)
Polycarbophilic vaginal moisturizing gel for the relief of severe
symptoms of vulvovaginal atrophy
Speaker: Ramón Usandizaga (Madrid, Spain)
Non-hormonal treatment of vasomotor symptoms in female patients with
and after breast carcinoma
Speaker: René Druckmann (Nice, France)
Page 12 / 43
20 - 22.05.2105,
Madrid, Spain
The comparison betweenthe effects of hyaluronic acid vaginal
suppository and vitamin E on the treatment of atrophic vaginitis in
menopausal women
Speaker: Zahra Abbaspoor (Ahvaz, Iran, Islamic Republic of)
The effect of vitamin D suppository on atrophic vaginal mucosa in
menopausal women
Speaker: Mitra Tadayon Najafabadi (Ahvaz, Iran, Islamic Republic of)
Ibandronic acid subsequent to raloxifene: effect on bone metabolism and
on cardiovascular risk factors
Speaker: Antonio Cano (Valencia, Spain)
Effects of caffeine intake on bone tissue in an animal model of
osteoporosis
Speaker: Carla Vanin (Porto Alegre, Brazil)
Knowledge of osteoporosis by postmenopausal women from Seville’s
south sanitary area
Speaker: Eva María Iglesias (Sevilla, Spain)
Osteoporosis: where we come from and where we are going to
Speaker: Antonio Bazarra-Fernandez (A Coruña, Spain)
Efficacy and safety of Nigella sativa in the treatment of post-menopausal
osteoporotic women: a randomized double-blind placebo-controlled trial
Speaker: Shirin Hasani-ranjbar (Tehran, Iran, Islamic Republic of)
The association of 25 hydroxyvitamin D and hand grip strength in
Speaker: Miljanka Vuksanovic (Belgrade, Serbia)
Strontium ranelate, a drug under suspicion. Clinical results after 4 year
followup of a Mediterranian cohort
Speaker: Melchor Carbonell Socias (Barcelona, Spain)
Accuracy of quantitative ultrasound technique and osteoporosis selfassessment tool in comparison to DXA in detecting low bone density in
post-menopausal women in Riyadh, Saudi Arabia
Speaker: AlJohara Alquaiz (Riyadh, Saudi Arabia)
Antipsychotic-induced hyperprolactinaemia: adapting guidelines to
overcome challenges posed by this group of women
Speaker: Jan Brockie (Oxford, United Kingdom)
The role of vitamin D in osteoporosis
Relationship between serum levels of Vitamin D and urinary calcium
levels
Relationship between urinary calcium and treatment with antiosteoporotic drugs
Vitamin D levels in Almeria women and its relationship with calcium
and/or vitamin D supplements
Page 13 / 43
20 - 22.05.2105,
Madrid, Spain
Association between bone mineral density and metabolic syndrome in
postmenopausal Turkish women
Speaker: Berna Dilbaz (Ankara, Turkey)
Bone and fat interconnection in women with estrogen deficit
Speaker: Antonina Smetnik (Moscow, Russian Federation)
Postmenopausal osteoporosis
Renal function is associated with bone mineral density and arterial
stiffness in healthy postmenopausal women
Speaker: Yeon Soo Jung (Goyang, Korea, Republic of)
Improving osteoporosis treatment adherence: the importance of specific
consultations
Speaker: María Gonzalez Garcia (Oviedo, Spain)
Epidemiological features of Spanish postmenopausal women attended at
outpatient gynaecology. Postmenopausal osteoporosis risk calculation
based on FRAX
Speaker: Antonio Carballo (Jaén, Spain)
Association of fear of falling and falls history with postural stability in
Spanish postmenopausal women
Association between menopausal age and type 2 diabetes mellitus
(T2DM) in women with osteoporosis (OS) and hypovitaminosis D
Speaker: Sanja Borozan (Podgorica, Montenegro)
Genetic influences on bone density: vitamin D receptor gene alleles and
the effect of hormone therapy on postmenopausal bone loss
Speaker: Camil Castelo-Branco (Barcelona, Spain)
Safety and efficacy of ossein-hydroxyapatite complex for the prevention
of osteoporosis during perimenopause. A three year follow-up study
Speaker: José Manasanch-Dalmau (Barcelona, Spain)
Assessment of the association hormone replacement therapy (HRT) /
denoxumab in patients whose bone mineral density not respond to
treatment of simultaneous HRT / bisphosphonates
Speaker: JL Cuadros (Granada, Spain)
Bone density in patients with cervical cancer or endometrial cancer in
comparison with healthy control, according to the stages
Speaker: Hoon Choi (Seoul, Korea, Republic of)
Changes in bone density after cancer treatment in patients with
cervicaland endometrial cancer
Speaker: Hoon Choi (Seoul, Korea, Republic of)
Associations between dietary calcium intake with prevalence of
metabolic syndrome and changes in bone mineral density among Korean
population
Speaker: Seok Kyo Seo (Seoul, Korea, Republic of)
Page 14 / 43
20 - 22.05.2105,
Madrid, Spain
Replication study of genetic loci influencing age at menopause in
Southern Chinese women
Speaker: Hang Wun Raymond Li (Hong Kong, Hong Kong)
Efficacy of long-term dienogest treatment for endometriosis recurrency
in premenopausal women
Speaker: Elvira Bratila (Bucharest, Romania)
Levonorgestrel IUD in the perimenopause, treatment or contraceptive?
Speaker: Veronica Martinez Vidal (Guadalajara, Spain)
Heavy menstrual bleeding in perimenopausal women
Speaker: Michèle Lachowsky (Paris, France)
Do the restricting guidelines of certain official state agencies have a
major impact on health care personnel’s (essentially gynecologists)
prescribing policies
Natural progesterone: interest in medical care of women in peri and post
menopause
Endometrial histology and safety in healthy permenopausal and early
postmenopausal women after an oral fourphasic contraceptive. Results
after 2 years monitoring
Speaker: Manuela Russu (Bucharest, Romania)
Disfuntional uterine bleeding in perimenopausal patients
Speaker: Odeta Hoxhaj (Tirana, Albania)
Page 15 / 43
20 - 22.05.2105,
Madrid, Spain
Thursday, 21 May 2015
Society Symposia
08:00 - 09:00
Roma
Indian Menopause Society Focus on Midlife health in India
Chairs:
Chair: Mary Ann Lumsden (United Kingdom)
As an Indian do my ovaries behave differently?
08:00 - 08:25
Speaker: Duru Shah (India)
Sexuality Concerns & care at Midlife
08:25 - 08:50
Speaker: Sunila Khandelwal (India)
Questions & Answers
Society Symposia
08:00 - 09:00
08:50 - 09:00
Potsdam-Stuttgart
Hellenic Menopause Society Customizing menopausal hormone therapy in clinical
practice
Chairs:
Chair: George Christodoulakos (Greece)
Hormone replacement therapy in premature ovarian insufficiency
08:00 - 08:15
Speaker: Sofia Kalantaridou (Greece)
Hormone therapy during the transition and the early postmenopausal
period: choosing the estrogen
08:15 - 08:30
Hormone therapy during the transition and the early postmenopausal
period: choosing the progestogen
08:30 - 08:45
Low dose vaginal estrogen therapy
08:45 - 09:00
Speaker: Areti Augoulea (Greece)
Society Symposia
08:00 - 09:00
Session Room Milan
International Society of Gynecological Endocrinology Estrogens as Antiaging
Therapy
Chairs:
Chair: Bart Fauser (Utrecht, Netherlands)
Page 16 / 43
20 - 22.05.2105,
Madrid, Spain
Estrogens as antiaging therapy - brain and nerves
08:00 - 08:15
Speaker: Andrea R. Genazzani (Pisa, Italy)
Kidney and urinary tract
08:15 - 08:30
Speaker: Angelica Lindén Hirschberg (Stockholm, Sweden)
Vagina and vulva
08:30 - 08:45
Heart and vessels
08:45 - 09:00
Society Symposia
08:00 - 09:00
Korean Menopause Society Postmenopausal Hormone therapy : prospective
treatments for better quality of life
Chairs:
Chair: Hoon Choi (Seoul, Korea, Republic of)
Chair: Byung Seok Lee (Seoul, Korea, Republic of)
Screening for cardiovascular risk in postmenopausal women
08:00 - 08:20
Speaker: Seok Kyo Seo (Seoul, Korea, Republic of)
Hormone therapy and breast cancer: recent guideline
08:20 - 08:40
Speaker: Dong-Yun Lee (Seoul, Korea, Republic of)
Discussion time
Plenary Session
09:15 - 10:15
08:40 - 09:00
Roma
Osteoporosis screening and therapeutic advances
Chairs:
Chair: Florence Tremollieres (Toulouse, France)
FRAX - where are we now?
09:15 - 09:45
Speaker: Juliet Compston (Cambridge, United Kingdom)
New anabolic and antiresorptive strategies for osteoporosis
Speaker: René Rizzoli (Geneva, Switzerland)
Page 17 / 43
09:45 - 10:15
20 - 22.05.2105,
Madrid, Spain
Parallel Session
11:00 - 12:15
Roma
Breast cancer
Chairs:
Chair: Rebecca Glaser (Dayton, United States)
Individualising mammography
11:00 - 11:15
Speaker: Joëlle Desreux (Liège, Belgium)
Molecular portraits for predicting tumour resistance to hormonal
therapies in postmenopausal women
11:15 - 11:30
Speaker: Thierry Maudelonde (Montpellier, France)
Therapeutic advances for breast cancer: role of stem cells
11:30 - 11:45
Speaker: Ludwig Kiesel (Münster, Germany)
Progestogens and the breast
11:45 - 12:00
Speaker: Anne Gompel (France)
Parallel Session
11:00 - 12:15
12:00 - 12:15
Potsdam-Stuttgart
Gynecological cancer
Chairs:
Chair: Richard Anderson (Edinburgh, United Kingdom)
Chair: Bart Fauser (Utrecht, Netherlands)
Screening for uterine cancer: for whom and when
11:00 - 11:15
Speaker: Lian Ulrich (Copenhagen O, Denmark)
Screening for ovarian cancer
11:15 - 11:30
Speaker: Sean Kehoe (Birmingham, United Kingdom)
Lifestyle and hormones and gynecological cancer
11:30 - 11:45
Speaker: Martin Birkhäuser (Basel, Switzerland)
Treatment of climacteric symptoms in survivors of gynecological cancer
11:45 - 12:00
Speaker: Nicoletta Biglia (Italy)
Sponsored Symposium
11:00 - 12:15
Estetrol and Breast Cancer
Chairs:
Chair: Herjan J.T. Coelingh Bennink (AL Zeist, Netherlands)
Page 18 / 43
12:00 - 12:15
Session Room Milan
20 - 22.05.2105,
Madrid, Spain
Modulatory effects of E4 on breast cancer cell invasion
11:00 - 11:15
Effect of estetrol in the DMBA induced breast carcinoma model
11:15 - 11:30
Speaker: Lenus Kloosterboer (Netherlands)
Estetrol has selective estrogen receptor modulating effects on the breast
11:30 - 11:45
Speaker: Jean Michel Foidart (Belgium)
Antiestrogenic effects of E4 on estrogen-receptor positive early breast
cancer
11:45 - 12:00
Speaker: Christian Singer (Australia)
Discussion
Parallel Session
11:00 - 12:15
12:00 - 12:15
Screening for osteoporosis
Chairs:
Chair: Florence Tremollieres (Toulouse, France)
Chair: Pedro Abizanda (Albacete, Spain)
Fracture risk prediction in clinical practice
11:00 - 11:15
Speaker: Tineke van Geel (Maastricht, Netherlands)
Screening for osteoporosis after breast cancer: for whom and when
11:15 - 11:30
Speaker: Florence Tremollieres (Toulouse, France)
Screening for risk of falls in older adults
11:30 - 11:45
Speaker: Javier Ferrer (Spain)
Sarcobesity and osteoporosis
11:45 - 12:00
Speaker: Fidel Hita Contreras (Spain)
12:30 - 13:30
12:00 - 12:15
Roma
Psychosomatic and sexual medicine in routine practice
Chairs:
Chair: Iuliana Ceausu (Bucharest, Romania)
Psychosocial & sexual medicine in routine practice
12:30 - 13:00
Prevalence and determinants of female sexual dysfunction in Latin
America
Page 19 / 43
13:00 - 13:30
20 - 22.05.2105,
Madrid, Spain
12:30 - 13:30
Potsdam-Stuttgart
Managing the menopause without estrogen
Chairs:
Chair: Tomi Mikkola (Finland)
Speaker
12:30 - 12:50
Speaker: Johannes Huber (Austria)
Managing the menopause without oestrogen
12:50 - 13:10
Speaker: Rod Baber (Mosman, Australia)
Managing the menopause without estrogen
13:10 - 13:30
Speaker: Jenifer Sassarini (Glasgow, United Kingdom)
Oral Presentations
12:30 - 13:30
Chairs:
Chair: Cemal Tamer Erel (Istanbul, Turkey)
Cimicifuga Racemosa (CR) safety: pre- and clinical evidence for lack of
Widespread Estrogenic rick
Speaker: Susana Garcia de Arriba (Salzgitter, Germany)
Current status of physicians’ awareness and clinical practice of
menopause hormone replacement therapy in China: A multicenter, crosssectional survey
Speaker: Rong Chen (Peking, China)
The development of Malignant or Benign Endometrial Pathology is
associated with the expression of gondal steroid receptors in
postmenopausal ovaries
Speaker: Eleni Armeni (Athens, Greece)
Comparison of lipid profiles among Chinese breast cancer patients with
or without chemotherapy-induced menopaus
Speaker: Winnie Yeo (Hong Kong, Hong Kong)
iCIMICIFUGA Extract Modulates Brain Aactivity; Electropharmacogram
from various brain areas in freely moving rats (TELE-STEREO-EEG)
Speaker: Susana Garcia de Arriba (Salzgitter, Germany)
NOVEL Laser and Radio-Frequency (RF) procedures in gynecology
Speaker: Ivan Fistonic (Zagreb, Croatia)
Page 20 / 43
Session Room Milan
20 - 22.05.2105,
Madrid, Spain
Society Symposia
12:30 - 13:30
Spanish Menopause Society: For promoting translation of science into clinical
practice… The “MenoGuías”.
One of the main objectives of the Spanish Menopause Society (AEEM) is to transfer the wealth of scientific information
that appears every day in recommendations for practitioners to implement them in the care of mature woman. Such
guidelines are traditionally the result of consensus with other Societies or expert panels and represent attempts to
synthesize —from the best available evidence and expertise— practical guidance on the best possible care. The
emergence of "MenoGuías" of AEEM has favoured the spread and management of various conditions affecting women
on midlife health and beyond.
Chairs:
1. The GRADE System for Rating Clinical Guidelines
12:30 - 12:45
2. Postmenopausal Risk factors assessment. Molecular and genetic
diagnostics
12:45 - 13:00
3. Vaginal Health
13:00 - 13:15
Speaker: Montse Manubens (Spain)
4. Osteoporosis and osteoarthritis prevention
13:15 - 13:30
Speaker: Javier Ferrer (Spain)
Sponsored Symposium
14:00 - 15:30
Roma
Vagina Dialogues: An enigma of partnership in mid-life
Chairs:
Welcome
14:00 - 14:05
Vaginal health: It takes two to tango!
14:05 - 14:30
Speaker: Sheryl Kingsberg (United States)
Vaginal health: When women talk!
14:30 - 14:50
Speaker: Kathryn Colas (United Kingdom)
Speaker: Heather Currie (United Kingdom)
Vagifem® 10µg: Patient’s preference matters!
14:50 - 15:15
Speaker: Marla Shapiro (Canada)
Panel discussion and concluding remarks
Page 21 / 43
15:15 - 15:30
20 - 22.05.2105,
Madrid, Spain
Parallel Session
16:00 - 17:30
Roma
Cardiovascular disease hormones and thrombosis
Chairs:
Chair: James Simon (United States)
Chair: Iñaki Lete (Spain)
Hormone therapies and ischemic heart disease
16:00 - 16:15
Hormone therapy and venous thromboembolism among postmenopausal
women
16:15 - 16:30
Speaker: Marianne Canonico (Villejuif, France)
Hormone therapies and stroke
16:30 - 16:45
Speaker: Sven O. Skouby (Denmark)
Managing CHD: gender differences
16:45 - 17:00
Speaker: Karin Schenck-Gustafsson (Stockholm, Sweden)
Parallel Session
16:00 - 17:30
17:00 - 17:30
Potsdam-Stuttgart
Brain ageing, sarcopenia and frailty
Chairs:
Chair: Mary Ann Lumsden (United Kingdom)
Chair: Johannes Huber (Austria)
Verbal memory and dementia
16:00 - 16:15
Speaker: Pauline Maki (United States)
Brain ageing in women
16:15 - 16:30
Parkinson’s disease
16:30 - 16:45
Speaker: Maria Blanco-Prieto (Spain)
Sarcopenia and frailty
16:45 - 17:00
Speaker: Vincenzo Malafarina (Logroño, Spain)
Oral Presentations
16:00 - 17:30
Oral Presentation 3
Chairs:
Chair: Camil Castelo-Branco (Barcelona, Spain)
Chair: Antonio Cano (Valencia, Spain)
Page 22 / 43
17:00 - 17:30
Session Room Milan
20 - 22.05.2105,
Madrid, Spain
ER:YAG laser treatment for stress urinary incontinence (SUI) in women
16:00 - 16:11
Speaker: Ivan Fistonić (Zagreb, Croatia)
Hormone replacement therapy and lipid oxidation in isolated vascular,
hepatic and renal rat tissue: a possible link to atherosclerotic oxidative
physiopathology
16:11 - 16:22
Effects of the MHT and SERMs on progesterone/RANKL signaling in nonmalignant and malignant breast tissue of postmenopausal women
16:22 - 16:33
Speaker: Risto Erkkola (Turku, Finland)
Vaginal Erbium Laser: the second generation thermotherapy for the
genitourinary syndrome of menopause (GSM). A pilot study
16:33 - 16:44
Speaker: Marco Gambacciani (Pisa, Italy)
Glomerular filtration rate is associated with subclinical atherosclerosis in
healthy postmenopausal women
16:44 - 16:55
Premenstrual syndrome and arterial stiffness
16:55 - 17:06
Speaker: Anastasia Sourreti (Athens, Greece)
Depression and the incidence of symptom of urinary incontinence among
young women: results from the Australian longitudinal study on women’s
health
17:06 - 17:18
Speaker: Timothy Hillard (Poole, United Kingdom)
The effect of menopause on the intervertebral discs
Oral Presentations
16:00 - 17:30
17:18 - 17:30
Oral Presentation 4
Chairs:
Chair: Jenifer Sassarini (Glasgow, United Kingdom)
Chair: Manuel Parra (Chile)
Attitudes and experiences of menopause amongst Macedonian women in
Australia
16:00 - 16:11
Speaker: John Eden (Sydney, Australia)
Quality of life in middle-aged women with chronic somatic diseases
16:11 - 16:22
Speaker: Paivi Polo Kantola (Finland)
Associations between postmenopausal hormone therapy and strokes in a
National cohort study
16:22 - 16:33
Speaker: Ellen Løkkegaard (Hillerød, Denmark)
Fertility preservation in young women with endometrial cancer
16:33 - 16:44
Speaker: Bjoern Signe Frahm (Copenhagen O, Denmark)
Steroid sulfatase activity in adipose tissue is higher in postmenopausal
than premenopausal women
Speaker: Hanna Paatela (Helsinki, Finland)
Page 23 / 43
16:44 - 16:55
20 - 22.05.2105,
Madrid, Spain
Risk of venous thromboembolism associated with local and systemic use
of hormone therapy in peri- and postmenopausal women in relation to
type of administration and progestagen type
16:55 - 17:06
Speaker: Ljiljana Kocoska-Maras (Stockholm, Sweden)
Plenary Session
18:00 - 19:00
17:06 - 17:19
Roma
Innovation in therapies for ageing
Chairs:
Chair: John Stevenson (London, United Kingdom)
Engineering the estrogen receptor for arterial protection
18:00 - 18:30
Speaker: Jean-Francois Arnal (Toulouse, France)
Non-hormonal treatments for sexual dysfunction in menopausal women
18:30 - 19:00
Speaker: James Simon (United States)
19:00 - 20:00
Roma
General Assembly
Poster Session
20:00 - 21:00
Poster Session 2
Age at natural menopause among rural women of Marrakech, Morocco
Speaker: Rania Lotfi (Marrakech, Morocco)
Antioxidant system in perimenopausal women
Speaker: Natalya Semenova (Irkutsk, Russian Federation)
Premature menopause and ovarian reserve in female survivors of
childhood cancer
Very rare causes of premature ovarian insufficiency: a report of two
cases
Speaker: Ozlem Dural (Istanbul, Turkey)
An audit of the diagnosis and management of patients with premature
ovarian failure (POF) within a menopause clinic based within a
community sexual and reproductive healthcare service
Page 24 / 43
Exhibition Area
20 - 22.05.2105,
Madrid, Spain
Observational epidemiological study in patients with premature ovarian
insufficiency in Spain. Preliminary results
Speaker: Misericordia Guinot Gasull (Barcelona, Spain)
Socio-economic factors in postmenopausal rating scale in Osun State,
South-Western Nigeria
Speaker: Joseph Kupoluyi (Ile-Ife, Nigeria)
Nigerian menopause rating scale (mrs). Experience in postmenopausal
women
Speaker: Joseph Kupoluyi (Ile-Ife, Nigeria)
The man in middle age: what to expect?
Speaker: Maria Presado (Lisboa, Portugal)
Quality of life in postmenopausal women: clinical effects of drospirenoneestradiol administration versus placebo
Speaker: Novella Russo (Gottaferrata, Italy)
The quality of life for women in a period of menopause
Speaker: Sergey Nedogoda (Volgograd, Russian Federation)
Patient characteristics and outcomes of an interdisciplinary menopause
clinic: a retrospective chart review
Speaker: Beate Sydora (Edmonton, Canada)
Correlation between the quality of life and sleep quality with the body
mass index in Colombian women in climacteric
Speaker: Alvaro Monterrosa-Castro (Cartagena, Colombia)
A randomised controlled trial on climacteric symptoms management and
quality of life improvement of Nigella sativa seeds powder in menopausal
women
Influence of drugs on sexuality among Slovenian menopausal women
Speaker: Lucija Vrabic Dezman (Kranj, Slovenia)
Vocal quality in postmenopausal women
Speaker: Tomasz Krecicki (Wroclaw, Poland)
Efficacy of an intimate hygiene wash solution on the global symptoms of
acute vulvovaginitis in menopause women
Speaker: Luis Sanfrutos (Madrid, Spain)
Predictive validity of the menopause health-related quality-of-life
(HRQoL) cervantes-short form scale
Speaker: Javier Rejas (Alcobendas, Spain)
Burden of menopausal vasomotor symptoms on work productivity and
daily-activity in a cohort of peri/post-menopausal women in daily practice
in Spain
Clinical usefulness of the menopause health-related quality-of-Life
(HRQoL) cervantes-short form scale
Page 25 / 43
20 - 22.05.2105,
Madrid, Spain
Migration and quality of life, a cross-cultural analysis in Tunisia and
France
Speaker: Henri Panjo (Le Kremlin-Bicêtre, France)
Apical vaginal prolapse. Is it really more common after vaginal
hysterectomy than after abdominal hysterectomy?
Speaker: Jose Luis Gallo Vallejo (Granada, Spain)
Results of the European REVIVE (REal Women’s VIew of Treatment
Options for Menopausal Vulvar/Vaginal ChangEs) survey
The cholinergic innervation features of overactive bladder in
perimenopausal women
Speaker: Bohdan Bidovanets (Ternopil, Ukraine)
An intimate hygiene wash solution in the management of acute
vulvovaginitis in menopause women
Speaker: Misericord Guinot (Barcelona, Spain)
Clinical outcomes of 3-day or 5-day treatment with clomiphene citrate
combined with gonadotropins and a timed intercourse cycle in PCOS
patients
Speaker: Jong Kil Joo (Busan, Korea, Republic of)
An unusual case of vulvar myoma
Speaker: Silvia Copado Salido (Granada, Spain)
Conservative management by hysteroscopy in submucosal myomas
Ulipristal acetate (UA) for treatment of fibroids: experience in 24
patients
Speaker: Margarita Elias Alguacil (Guadalajara, Spain)
How old is "too old" for hysterectomy?
Speaker: Esther Maor-Sagie (Jerusalem, Israel)
Local estrogenic therapy in patients with ASCUS. Review 2011-2013
Speaker: Milagros Martinez Medina (Sant Cugat del Valles, Spain)
Benign idiopathic pyometra in elderly women
Speaker: Diaz Begoña (Albacete, Spain)
Chronic pelvic pain: protocol in the unit
Speaker: Maryna Lapotka (Granada, Spain)
The role of transvaginal ultrasonography in the evaluation of endometrial
hyperplasia or cancer in pre- and perimenopausal women
Speaker: Sun Mie Kim (Seoul, Korea, Republic of)
Knowledge and attitudes regarding menorrhagia in Croatian women
Speaker: Dinka Baldani (Zagreb, Croatia)
Individualizing mammography
Page 26 / 43
20 - 22.05.2105,
Madrid, Spain
Intraoperative, histopathological examination of sentinel lymph node,
plays an important role in surgical treatment of breast cancer
Speaker: Barbara Madej (Lublin, Poland)
Temperature gradient in breast cancer thermographic imaging – a case
study
Speaker: Marko Mlinaric (Zagorje ob Savi, Slovenia)
Metabolic syndrome and prognostic factors in postmenopausal breast
cancer patients
Speaker: Daniel María Lubián López (Puerto Real, Spain)
Reduced incidence of breast cancer in women adherent to testosterone
or testosterone-anastrozole hormone therapy: updated interim analysis
Speaker: Rebecca Glaser (Dayton, United States)
Comparing breast cancer cell proliferation in sequential combined vs
continuous combined MHT regimens in cells overexpressing PGRMC1
Speaker: Alfred Mueck (Tuebingen, Germany)
Is breast cancer risk during treatment with estrogen and norethisterone
especially increased by overexpression of PGRMC1?
Estradiol metabolites as possible predictor for breast cancer? Two case
control studies comparing pre- and postmenopausal women
The body image and sexual experiences in female patients receiving
chemotherapy after mastectomy
Speaker: Nurgül Bölükbaş (ORDU, Turkey)
Prolactin promotes T47D cell motility through actin cytoskeleton
Speaker: Vinicius Cestari do Amaral (Pisa, Italy)
Systematic review: treatment of atrophic vaginitis in breast cancer
patients treated with aromatase inhibitors
Speaker: Aurelie Joris (Brussels, Belgium)
Emotional status of breast cancer patients: a qualitative study
Usefullness of menstruation or serum hormone levels as markers for
protection using gonadotropin-releasing hormone agonist against
chemotherapy-induced ovarian damage in young breast cancer patients
Speaker: Dong-Yun Lee (Seoul, Korea, Republic of)
Can estradiol metabolites be used as predictor for breast cancer risk in
pre- and postmenopausal women?
Systematic review about breast cancer incidence in relation to hormone
replacement therapy use
Estradiol concentration in breast tissue obtained during surgery in
women taking oral contraceptives or adjuvant endocrine therapy
Speaker: Herman Depypere (Ghent, Belgium)
Page 27 / 43
20 - 22.05.2105,
Madrid, Spain
Comparison the effectiveness and side effects of two methods of
emergency contraception: levonorgestrel versus LD, HD
Contraceptive use and unintended pregnancy in Isfahan, Iran in 2012
Case report: contraceptive options and reproductive health implications
for a 19 year old female patient with a maternal history of the BRCA2
gene mutation
Tropical plants with fertility and infertility value
Speaker: Saganuwan Alhaji Saganuwan (Makurdi, Nigeria)
Polycystic ovary syndrome in a patient with pituitary apoplexy-case
report
Speaker: Aleksandar Djogo (Podgorica, Montenegro)
Histeroscopic diagnosis in postmenopausal metrorrhage
Speaker: Maria Teresa Maroto Martín (Granada, Spain)
Ovarian cysts in postmenopausal women. Surgery and surgical approach
Speaker: Maria Teresa Maroto Martín (Granada, Spain)
Effect of endometrial thickness on endometrial pathology in a group of
postmenopausal women in the south area of Sevilla
Speaker: Pamela Valdivieso Mejía (Sevilla, Spain)
Differences after cervical conization in pre and posmenopausal women
Speaker: Jordi Leira (Sant Cugat del Valles, Spain)
Endometrial cáncer and hormonal therapy (HT)
Speaker: Laura Baquedano Mainar (Zaragoza, Spain)
Causes of postmenopausal bleeding
Speaker: Jorge Fernández Parra (Granada, Spain)
Distribution of abnormal vaginal bleeding In population sample
gynaecological women hospitalising in our hospital during last two years
Speaker: Albert Cakoni (Tirana, Albania)
Extensive high grade dysplastic changes superimposed on extensive
squoamos metaplasia of the surface endometrium. A case report
Speaker: Manuela Russu (Bucharest, Romania)
Factor of proliferation KI67 in early endometrial cáncer
The role of transvaginal elastosonography in the differential diagnosis of
endometrial carcinoma and hyperplasia during post-menapousal period
Speaker: Hasan Aydin (Ankara, Turkey)
Parameters linked with malignancy in postmenopausal endometrial
polyps
Page 28 / 43
20 - 22.05.2105,
Madrid, Spain
Retrocrural lymph node removal in the surgical management of ovarian
cancer
Speaker: Yong Jung Song (Yangsan-si, Gyeongsangnam-do, Korea, Republic of)
Retrospective analysis of endometrial pathology and thickness in
Speaker: Naoyo Nishida (Kurume, Japan)
Malignant diseaes of the female genital organs on the territory the
Grocka Municipality for the period 2004-2013. Good preventive
measures?
Speaker: Ivana Pekic (Grocka-Belgrade, Serbia)
The effect of hysteroscopy in postmenopausal bleeding
Speaker: Hyuk Jung (Gwanju, Korea, Republic of)
The relationship between obesity/overweight and female sexual function
Speaker: Mojgan Javadnoori (Ahvaz, Iran, Islamic Republic of)
Sexual function assessment with the 6-item FSFI in postmenopausal
Colombian women
Speaker: Alvaro Monterrosa-Castro (Cartagena, Colombia)
Are sexual health clinicians discussing menopausal symptoms in older
women attending for routine cervical screening?
Speaker: Nicola Mullin (Chester, United Kingdom)
Abdominal and laparoscopic sacrocolpopexy (LSCP) / sacrohysteropexy
(LSHP) methods in the treatment of pelvic organ prolapse (POP)
New alternative for treatment of advanced uterovaginal prolapse in
Speaker: Elvira Bratila (Bucharest, Romania)
Surgery for vaginal vault prolapsed – single center experience
Abdominal and laparoscopic sacrocolpopexy (LSCP)/ sacrohysteropexy
(LSHP) methods in the treatment of pelvic organ prolapse (POP)
Speaker: Abdullah Serdar Açıkgöz (İstanbul, Turkey)
Efficacy and quality of life after 10 years of transobturator tape surgery
for stress urinary incontinence
Adherence to treatment and characteristics of 59 patients treated with
mirabegron
Speaker: Bárbara Padilla-Fernández (La Laguna, Spain)
Long-term efficacy of the treatment with intravesical chondroitin sulfate
in women with painful bladder syndrome/interstitial cystitis
Efficacy of Botulinum toxin in women with overactive bladder according
to the dose injected
Page 29 / 43
20 - 22.05.2105,
Madrid, Spain
Friday, 22 May 2015
Society Symposia
08:00 - 09:00
Roma
European Society of Gynecology Estradiol and Progesterone: From Molecular
Biology To Clinics
Chairs:
Chair: Andrea R. Genazzani (Pisa, Italy)
Chair: Sven O. Skouby (Denmark)
Molecular signaling of steroid receptors. Undermining the basis of tissue
selectivity
08:00 - 08:20
Estetrol, the first identified natural Selective Estrogen Receptor
Modulator
08:20 - 08:40
Progesterone, Progestins, and SPRMs, what should we use, when?
08:40 - 09:00
Society Symposia
08:00 - 09:00
Potsdam-Stuttgart
Society Symposium COGI - PCOS during perimenopause
What do we know about the true cardiovascular risk in PCOS?
08:00 - 08:20
Speaker: Bart Fauser (Utrecht, Netherlands)
Is ovarian aging delayed in PCO/PCOS patients?
08:20 - 08:40
Speaker: Zion Ben-Rafael (Israel)
The menopausal transition in PCOS
08:40 - 09:00
Society Symposia
08:00 - 09:00
Belgium Menopause Society Is current HRT safe for the breast
Chairs:
Chair: Axelle Pintiaux (Belgium)
Chair: Serge Rozenberg (Belgium)
Menopausal hormone therapy use in relation to breast cancer incidence
in 11 European countries
Page 30 / 43
Session Room Milan
20 - 22.05.2105,
Madrid, Spain
Estradiol concentration in the breast in normal cycling women and
women taking tamoxifen
What is the right age for stopping cervical screening?
Sponsored Symposium
09:15 - 10:30
Treating oestrogen deficiency without oestrogen: a new approach to VVA
Chairs:
Unmet needs in VVA
09:15 - 09:30
Speaker: Alessandra Graziottin (Italy)
Senshio, a new oral treatment for VVA
09:30 - 09:45
Safety of Senshio, a new SERM for VVA
09:45 - 10:00
Speaker: Nicoletta Biglia (Italy)
Which of your patients are not candidates for local oestrogens?
10:00 - 10:15
Q&A / Panel discussion
Parallel Session
11:00 - 12:15
10:15 - 10:30
Roma
Predictors of disease in later life
Chairs:
Chair: Andrea R. Genazzani (Pisa, Italy)
Chair: Vincenzo Malafarina (Logroño, Spain)
Premenopausal risk factors for cardiovascular disease in later life
11:00 - 11:15
Predictors of mortality in older people
11:15 - 11:30
Long-term consequences of anorexia nervosa
11:30 - 11:45
Speaker: Blazej Meczekalski (Poznan, Poland)
Predicting frailty in older people
11:45 - 12:00
Speaker: Pedro Abizanda (Albacete, Spain)
Page 31 / 43
12:00 - 12:15
20 - 22.05.2105,
Madrid, Spain
Parallel Session
11:00 - 12:15
Potsdam-Stuttgart
Men’s health: the ageing male and andropause
Chairs:
Chair: Maria Blanco-Prieto (Spain)
Chair: Manuel Parra (Chile)
Late onset hypogonadism - in 2015
11:00 - 11:15
Speaker: Kevan Wylie (Sheffield, United Kingdom)
Diagnosing andropause
11:15 - 11:30
Speaker: Nikolaos Samaras (Geneva, Switzerland)
Cardiovascular disease and testosterone
11:30 - 11:45
Speaker: Mario Maggi (Florence, Italy)
Lifestyle predictors of healthy ageing in men
11:45 - 12:00
Speaker: Marita Södergren (Huddinge, Sweden)
Parallel Session
11:00 - 12:15
12:00 - 12:15
Session Room Milan
Menopause hormone therapy: for whom, when and what
Chairs:
Chair: Anne Gompel (France)
Chair: Marco Gambacciani (Pisa, Italy)
WHI: a decade beyond
11:00 - 11:15
KEEPS, DOPS and ELITE: where are we now
11:15 - 11:30
Speaker: Serge Rozenberg (Belgium)
Innovation in hormonal strategies
11:30 - 11:45
Traditional and innovative hormonal strategies for osteoporosis
11:45 - 12:00
Society Symposia
11:00 - 12:00
12:00 - 12:15
NCRI Symposium Hot flushes in breast cancer
Presented by the National Cancer Research Institute Breast Cancer Clinical Studies Group Working party on symptom
management
Supported by Breast Cancer Campaign
Page 32 / 43
20 - 22.05.2105,
Madrid, Spain
The impact of hot flushes on women with breast cancer
11:00 - 11:20
Speaker: Adrienne Morgan (London, United Kingdom)
Speaker: Deborah Fenlon (Southampton, United Kingdom)
Current management of hot flushes in breast cancer
11:20 - 11:40
Speaker: Dr Mei-Lin Ah-See (London, United Kingdom)
Non pharmacological management options for hot flushes after breast
cancer
11:40 - 12:00
Speaker: Myra Hunter (London, United Kingdom)
12:30 - 13:30
Roma
Fertility preservation
Chairs:
Chair: George Creatsas (Athens, Greece)
Fertility preservation
12:30 - 13:00
Speaker
13:00 - 13:30
Speaker: Joachim Calaf Alsina (Barcelona, Spain)
Oral Presentations
12:30 - 13:30
Chairs:
Hyaluronic acid concentration of diabetic rats' vaginas treated with
soybean Isoflavones or 17Β-Estradiol
Speaker: Vinicius Cestari do Amaral (Pisa, Italy)
Gene-gene interaction between single nucleotide polymorphisms in
ADAMTS5 and DRD3 is associated with premature ovarian failure
Speaker: SunYoung Park (Seongnam-si, Korea, Republic of)
The comparison of face to face with group education on sexual function
and satisfaction among postmenopausal Iranian women
Speaker: Parvin Abedi (Ahvaz, Iran, Islamic Republic of)
Efficacy of Phaleria macrocarpa extract on sperm quality in adult rats
Midlife sexuality concerns and care - an indian perspective
Speaker: Sunila Khandelwal (India)
Page 33 / 43
Potsdam-Stuttgart
20 - 22.05.2105,
Madrid, Spain
Sponsored Symposium
12:30 - 13:30
Session Room Milan
The use of bio-identical hormones for the treatment of menopausal symptoms
17β Estradiol and Natural Progesterone for Menopausal Hormone
Therapy: REPLENISH Phase 3 Study Design of a Combination Capsule and
Evidence Review
12:30 - 12:50
Speaker: Sebastian Mirkin (Philadelphia, United States)
Vagicap: a new solubilized vaginal estradiol for the treatment of vaginal
atrophy
12:50 - 13:10
Speaker: Brian Bernick (Boca Raton, United States)
Questions & Answers
Parallel Session
12:30 - 13:30
13:10 - 13:30
Dietary supplements and midlife health
Chairs:
Chair: Nick Panay (United Kingdom)
Chair: Javier Ferrer (Spain)
Supplements for whom and when: focus on calcium
12:30 - 12:45
Vitamin D and age-related conditions: current controversies
12:45 - 13:00
Speaker: Faustino Perez-Lopez (Zaragoza, Spain)
Vitamin K
13:00 - 13:15
Poster Session
13:30 - 14:30
Poster Session 3
Testosterone might be influenced by co-morbidities, not by aging
Speaker: Kwangmin Kim (Suwon, Korea, Republic of)
Testosterone levels in patients with major depression in a male
climacterium clinic
Speaker: Tsuchiya Tsubasa (Higashi-Osaka, Japan)
Testosterone serum levels reached with three testosterone preparations
in andropausia: its their impact on metabolic and biochemical
parameters
Speaker: Agustina Levalle (Buenos Aires, Argentina)
Page 34 / 43
13:15 - 13:30
Exhibition Area
20 - 22.05.2105,
Madrid, Spain
The protective effects of testosterone and insulin-like growth factor 1 on
bone mineral density decline with aging in men
Speaker: Kim Young-Sang (Seongnam, Korea, Republic of)
Evaluation of the efficacy and safety of Tribulus terrestris in male sexual
dysfunction – a prospective, randomized, double blinded, placebocontrolled clinical trial
Speaker: Zdravko Kamenov (Sofia, Bulgaria)
Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of
male wistar albino rats
Speaker: Osaro Erhabor (Sokoto, Nigeria)
Effect of non-polar extract of Phaleria macrocarpa (Mahkota dewa) on
serum testosterone level and libido behavior in male rats
On the potential effects of prostaglandin modulators and nonsteroidal
antinflammoatory drugs on erectile process, an in vitro study in rabbit
corpus cavernosum
Speaker: Amira Senbel (Alexandria, Egypt)
Andropause Phenomenon by measurement of serum free testosterone
concentration in Iraqi healthy men
Speaker: Basil Saleh (Baghdad, Iraq)
Sleep apnea and andropause: new approach to diagnosis of erectile
dysfunction
Speaker: Olga Berdina (Irkutsk, Russian Federation)
The life quality of patients who receving chemotherapy treatment after
mastectomy and stoma surgery
Speaker: Burçin Irmak (Ordu, Turkey)
Oestrogen patches (OP) to treat prostate cancer (PC) – Are different
commercial brands interchangeable?
Speaker: Ruth Langley (London, United Kingdom)
Quality of life assessment in cancer patients on chemotherapy
Results of trans obturator tape procedure in cerrahpasa faculty of
medicine
Speaker: Abdullah Serdar Açıkgöz (İstanbul, Turkey)
Urinary incontinence: should we treat the symptom or its impact on
quality of life?
Speaker: Paolo Mannella (Pisa, Italy)
Male patients with previous or ongoing prostate pathologies and
Botulinum toxin
Prevalence of metabolic syndrome and testosterone replacement therapy
in mans with andropause
Speaker: Sergey Nedogoda (Volgograd, Russian Federation)
Page 35 / 43
20 - 22.05.2105,
Madrid, Spain
Correlation between level of serum testosterone, PSA and prostate
volume among type 2 diabetics and nondiabetics
Speaker: Mohamed Mohieeldin Hashad (Alexandria, Egypt)
Setting the optimal intake of Omega-3 polyunsaturated fatty acids for
adult patients with hypertriglyceridemia in Moscow: the retrospective
study
Speaker: Leonid Vorslov (Moscow, Russian Federation)
Hydrogen activates ATP-binding cassette transporter A1-dependent
efflux ex vivo and improves high-density lipoprotein function in patients
with hypercholesterolemia: a double-blinded, randomised and placebocontrolled trial
Speaker: Shucun Qin (Taian, China)
The effect of menopause and gender on lipids and HDL cholesterol
subfractions in apparently healthy pre- and postmenopausal women and
men
Speaker: Panagiotis Anagnostis (London, United Kingdom)
Self-reported pregnancy complications and atherosclerosis in women
with ischemic heart disease
Speaker: Nina Johnston (Uppsala, Sweden)
Can addition of MHT increase benefial effects of statins in treating
postmenopausal women with known coronary heart disease?
Gender differences in blood pressure and electrocardiography
parameters in response to antihypertensive treatment
Speaker: Marina M. J. Romero-Prado (Guadalajara, Mexico)
The association of carotid artery intima-media thickness and
atherosclerosis-related factors, and the effects of interventions in
postmenopausal Japanese women
Speaker: Yoshiaki Somekawa (Toride, Japan)
The effect of testosterone levels on Vo2 max in type 2 diabetic patients
Speaker: Woong Choi (Seoul, Korea, Republic of)
Effects of menopause and menopausal transition phase on middle – aged
women’s mood and cognitive functions: a study in Greek naturally
menopaused women living in a rural isolated community
Speaker: Areti Augoulea (Greece)
The effects of age and menopause on verbal fluency
Speaker: Ramya Maitreyee (Sheffield, United Kingdom)
The development of mood disturbances is associated with levels of
circulating androgen in young postmenopausal women
Menopause attitude, body image and depression of women in menopause
Speaker: Nülüfer Erbil (Ordu, Turkey)
Do the psychological parameters differ among phenotypes of polycystic
ovary syndrome?
Speaker: Berna Dilbaz (Ankara, Turkey)
Page 36 / 43
20 - 22.05.2105,
Madrid, Spain
The effect of physical activity based on pedometer on depression,
anxiety and insomnia among postmenopausal women: a randomized
controlled trial
Speaker: Parvin Abedi (Ahvaz, Iran, Islamic Republic of)
Study of espresso coffees consumed in cafeterias from Pamplona, Spain
Nutrition and healthy aging with special reference to Western Rajasthan
Speaker: Manju Lata (Jaipur, India)
Dietary interventions with the Mediterranean diet outside Mediterranean
countries: a systematic review of intervention studies
Speaker: Jose Lara (Newcastle upon Tyne, United Kingdom)
Fortified bread in correction of vitamin D status
Speaker: Vladyslav Povoroznyuk (Kyiv, Ukraine)
Individual targeted therapy of vitamin D deficiency in postmenopausal
women with primary osteoarthritis
Impact on the somatic variation and body composition in women of
middle age with food supplement OBEX
Speaker: Consuelo Prado (Madrid, Spain)
Somatometric and clinical cardiovascular risk factors in midlife and older
women. A tale of four European countries
Screening of late onset male hypogonadisme with ADAM and AMS scores
and impact of cognitive functions
Speaker: Francois Allaert (Dijon, France)
Health in middle-aged and elderly women: a conceptual framework for
‘healthy menopause’
Speaker: Loes Jaspers (Rotterdam, Netherlands)
Clinical medication review as part of an elderly fallers patient care
screening service
Speaker: Nuttan Tanna (Harrow, United Kingdom)
Sexual and reproductive health needs of adult men in Ahwaz- Iran
Speaker: Mojgan Javadnoori (Ahvaz, Iran, Islamic Republic of)
Impact of former performed physical activity on body composition and
physical fitness in postmenopausal Spanish women
Speaker: R. Aparicio-Ugarriza (Madrid, Spain)
Prevalence of the rs9939609 polymorphism of the fat mass and obesity
(FTO) gene in postmenopausal women screened for metabolic syndrome
Searching the new markers of insulin resistance: what does the level of
hormones mean? The possible role of SHBG, testosterone, vitamin D and
increased active cell mass in diagnosing insulin resistance: the results of
a descriptive cross-sectional study
Speaker: Yulia Tishova (Moscow, Russian Federation)
Page 37 / 43
20 - 22.05.2105,
Madrid, Spain
HbA1c as predictor of pre-diabetes in middle aged women
Speaker: Sybille Bergmann (Dresden, Germany)
Metabolic impact of Nigella sativa supplementation in postmenopausal
women: a randomized, placebo-controlled trial
Prevalence of symptoms of benign prostatic hyperplasia in Umudike and
its relationship with measures of obesity
Speaker: Chukwunonso Ejike (Umuahia, Nigeria)
The prevalence of vitamin D deficiency (25-OH-D3) in obese patients in
Russia: a retrospective population study
Speaker: Daria Gusakova (Moscow, Russian Federation)
The effects of estrogen treatment on macrophage populations in adipose
tissue
Speaker: Tak Kim (Seoul, Korea, Republic of)
Monocyte chemoattractant protein-1 is associated with intermuscular
adipose tissue of thigh in obese Korean women
Speaker: Young-Sang Kim (Seongnam, Korea, Republic of)
The relationship between serum ferritin levels and the obesity in Korean
women
Speaker: Min Kyoung Kim (Seoul, Korea, Republic of)
Current evidence on risk factors for knee osteoarthritis related to
hormones or reproductive history
Speaker: Nathaly Gaudreault (Sherbrooke, Canada)
The FRAX calculator: the effect of years since menopause in FRAX
estimated risk in Romanian menopausal subjects
Nutritional status in elderly people with hip fracture: influence on
functional recovery and association with cognitive impairment
Pain syndrome, functional activity and quality of life in postmenopausal
women with knee osteoarthritis depending on the parameters of bone
mineral density
Speaker: Nataliia Grygorieva (Kyiv, Ukraine)
Trabecular bone score and bone mineral density in Ukrainian normal
women depending on duration of postmenopausal period
Hyperuricemia, bone mineral density and TBS of Ukrainian men
Trabecular bone score, bone mineral density and late-onset
hypogonadism in Ukrainian men of various ages
Gender features of vertebral pain syndrome depending on bone mineral
density
Page 38 / 43
20 - 22.05.2105,
Madrid, Spain
Association between neuropeptides gene polymorphisms and bone
response to hormone therapy in postmenopausal Korean women
Speaker: Jung Gu Kim (Seoul, Korea, Republic of)
Elderly men with hypogonadism and osteoporosis. Lack of response to
testosterone therapy and the effect of denosumab as an alternative to
antiresorptive therapy
Speaker: Agustina Levalle (Buenos Aires, Argentina)
Sarcopenia In Ukrainian women: assessment and determination of lean
body mass deficiency
The prevalence of vitamin D deficiency (25-OH-D3) in patients with
muscle mass deficit (sarcopenia) in Russia: a retrospective population
study
Speaker: Daria Gusakova (Moscow, Russian Federation)
Proliferative effect of Hachimijiogan, a Japanese herbal medicine, in
C2C12 skeletal muscle cells
Speaker: Takashi Takeda (Osaka, Japan)
The parathormon levels in 399 Romanian menopausal women with
hypovitaminosis D
Personal profile of the breast cancer screening in peri and
postmenopausal gynecologist members of the Spanish association of
menopause study. CHUSES study
Speaker: Maria Cancelo Hidalgo (Guadalajara, Spain)
Breast cancer screening behaviors among women above 40 years in
Hamadan, Iran
Speaker: Parisa Parsa (Hamadan, Iran, Islamic Republic of)
Personal profile of the cervix cancer screening in peri and
postmenopausal gynecologist members of the Spanish association of
menopause study. CHUSES study
Speaker: Maria Cancelo Hidalgo (Guadalajara, Spain)
Bioinformatic identification of potential sacrificial proteins in ageing
tissues
Speaker: Michael Sherratt (Manchester, United Kingdom)
Sleep disorders in postmenopausal women: lipid peroxidation and
antioxidant system
Speaker: Natalya Semenova (Irkutsk, Russian Federation)
A longitudinal evaluation of age, ovarian follicular depletion, and spatial
memory performance in a rat model of transitional menopause
Speaker: Stephanie Koebele (Tempe, United States)
Chronic calcium administration stimulates thyroid C-cells activity and
protects trabecular bone in a male rat model of osteoporosis
Speaker: Branka Sosic-Jurjevic (Belgrade, Serbia)
Soy phytoestrogen genistein increases liver deiodinase type 1 enzyme
activity in the rat models of menopause and andropause
Speaker: Branka Sosic-Jurjevic (Belgrade, Serbia)
Page 39 / 43
20 - 22.05.2105,
Madrid, Spain
The capacity for ACTH and corticosterone secretion in an animal model of
the andropause after treatment with testoterone
Speaker: Branka Šošić-Jurjević (Belgrade, Serbia)
Gluthathione peroxidase (GPX) level as a marker of menopausal
complaints severity degree amount paramedics women working at H.
Adam Malik Hospital in Medan, Indonesia
Speaker: Muhammad Fidel Ganis Siregar (Medan, Indonesia)
Erythrina lysistemon - derived flavonoids account only in part for the
plant’s specific effects on rat uterus and vagina
Speaker: Marie Alfrede Mvondo (Dschang, Cameroon)
Self-organising maps for the analysis of data from big cohorts. The case
of the Spanish CARMEN cohort
Plenary Session
14:30 - 15:30
Roma
Menopause and society
Chairs:
Chair: Karin Schenck-Gustafsson (Stockholm, Sweden)
Menopause in the workplace
14:30 - 15:00
Speaker: Serge Rozenberg (Belgium)
The burden of menopause on women and society
15:00 - 15:30
Parallel Session
16:00 - 17:30
Roma
Contraception in the perimenopause
Chairs:
Chair: Ludwig Kiesel (Münster, Germany)
Chair: Jean Michel Foidart (Belgium)
Contraception in the perimenopause: an integral approach
16:00 - 16:15
Oral contraception for midlife women
16:15 - 16:30
Estradiol - containing contraceptives
16:30 - 16:45
Speaker: George Creatsas (Athens, Greece)
Contraception in the perimenopause
Speaker: Iñaki Lete (Spain)
Page 40 / 43
16:45 - 17:00
20 - 22.05.2105,
Madrid, Spain
Parallel Session
16:00 - 17:30
17:00 - 17:30
Potsdam-Stuttgart
Complementary and alternative medicine and nutrition for older women
Chairs:
Chair: Mario Maggi (Florence, Italy)
Chair: Blazej Meczekalski (Poznan, Poland)
Herbal medicines for menopausal symptoms
16:00 - 16:20
Speaker: Wolfgang Wuttke (Bovenden, Germany)
Isoflavones and the gut microbiome
16:20 - 16:40
Chocolate and coffee for older people
16:40 - 17:00
Oral Presentations
16:00 - 17:30
17:00 - 17:30
Session Room Milan
Oral Presentation 5
Chairs:
Chair: Serge Rozenberg (Belgium)
Direct and indirect effects of conjugated estrogens/bazedoxifene
treatment on quality of life in postmenopausal women
16:00 - 16:11
Speaker: Lucy Abraham (Tadworth, United Kingdom)
Management of hot flushes in UK breast cancer patients: comparing the
clinician and patient perspective
16:11 - 16:22
Speaker: Deborah Fenlon (Southampton, United Kingdom)
To exercise or not to exercise: relationship between menopausal
experience and exercise avoidance
16:22 - 16:33
Speaker: Lily Stojanovska (Melbourne, Australia)
Long-term effect of physical activity on menopause-related quality of life
– a 4 year follow-up study of a randomized controlled trial
16:33 - 16:44
Speaker: Kirsi Mansikkamäki (Tampere, Finland)
Estrogen mediates the mechanical properties of skin and prevents elastic
fibre degeneration
16:44 - 16:55
Speaker: Michael Sherratt (Manchester, United Kingdom)
Vaginal physical examination correlates with vaginal epithelial cells and
pH and can be used to assess treatment efficacy of vulvar and vaginal
atrophy (VVA) with a novel 10 µg vaginal gelcap (VagiCap™)
Speaker: Ginger Constantine (Malvern, United States)
Page 41 / 43
16:55 - 17:06
20 - 22.05.2105,
Madrid, Spain
Cross-sectional assessment of resilience in peri- and postmenopausal
Spanish women
17:06 - 17:17
Speaker: Pluvio Coronado (Madrid, Spain)
Oral Presentations
16:00 - 17:30
17:17 - 17:30
Oral Presentation 6
Chairs:
Clinical long term outcome and re-interventional rate after uterine
fibroid embolization
16:00 - 16:11
Speaker: Stevo Duvnjak (Odense, Denmark)
Comparison of efficacy of oral contraceptive pill versus hormone
replacement therapy in premature ovarian insufficiency
16:11 - 16:22
Speaker: Vikram Sinai Talaulikar (London, United Kingdom)
The efficacy of an exercise and lifestyle intervention for postmenopausal
women living in North Queensland
16:22 - 16:33
Speaker: Fiona Barnett (Townsville, Australia)
Menopausal hormone therapy use in 17 European countries during the
last decade
16:33 - 16:44
Coping with menopausal symptoms: an internet survey of Belgian
16:44 - 16:55
Migration may influence major depressive disorder in middle-aged
women
16:55 - 17:06
Speaker: Elsa Jacquet (Le Kremlin-Bicêtre, France)
Acupuncture for the treatment of hot flashes in breast cancer patients, a
randomized, controlled trial, with long-term quantitative and qualitative
follow up
17:06 - 17:18
Speaker: Jill Hervik (Tonsberg, Norway)
Vertebral fracture prevalence among Greek healthy middle-aged
postmenopausal women:association with demographics, anthropometric
parameters and bone mineral density
Page 42 / 43
17:18 - 17:30
20 - 22.05.2105,
Madrid, Spain
Plenary Session
18:00 - 19:00
Roma
Breast cancer prevention
Chairs:
Chair: Alfred Mueck (Tuebingen, Germany)
Chair: Tommaso Simoncini (Italy)
Testosterone and breast cancer prevention
18:00 - 18:30
Speaker: Rebecca Glaser (Dayton, United States)
Chemoprevention or mastectomy for high risk women
18:30 - 19:00
Speaker: Piero Sismondi (Italy)
Opening Ceremony / Closing Ceremony
19:00 - 20:00
Closing Ceremony
Chairs:
Page 43 / 43
Powered by TCPDF (www.tcpdf.org)
Roma

Scientific Programme Wednesday, 20 May 2015 Society Symposium

Transcription

Similar documents

Final list of references supporting the assessment report on: Hyperici